VA awards $5M for heart implants, highlighting potential for improved patient outcomes and specialized medical device manufacturing

Contract Overview

Contract Amount: $50,029 ($50.0K)

Contractor: Edwards Lifesciences LLC

Awarding Agency: Department of Veterans Affairs

Start Date: 2026-04-07

End Date: 2026-05-08

Contract Duration: 31 days

Daily Burn Rate: $1.6K/day

Competition Type: NOT COMPETED

Number of Offers Received: 1

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: PROSTHETICS - HEART IMPLANT

Place of Performance

Location: PALO ALTO, SANTA CLARA County, CALIFORNIA, 94304

State: California Government Spending

Plain-Language Summary

Department of Veterans Affairs obligated $50,029.04 to EDWARDS LIFESCIENCES LLC for work described as: PROSTHETICS - HEART IMPLANT Key points: 1. The contract value of $5,000,290 for heart implants suggests a significant investment in advanced cardiovascular technology. 2. The sole-source nature of this award warrants scrutiny regarding the justification for limited competition. 3. The short duration of the contract (31 days) may indicate an urgent need or a pilot program. 4. The specific product code (339113) points to a specialized area within medical device manufacturing. 5. The award to Edwards Lifesciences LLC, a known entity in the medical device sector, provides some level of performance predictability.

Value Assessment

Rating: fair

Benchmarking the value of this specific heart implant contract is challenging without detailed product specifications and market analysis. However, the $5 million award for a 31-day period suggests a high per-unit cost, typical for advanced medical devices. Comparing this to similar sole-source procurements for specialized cardiovascular equipment would be necessary to fully assess value for money. The fixed-price nature of the contract provides some cost certainty for the government.

Cost Per Unit: N/A

Competition Analysis

Competition Level: sole-source

This contract was awarded on a sole-source basis, meaning it was not openly competed. The justification for this approach is not provided in the data, but it typically arises when only one vendor can meet the specific requirements, such as proprietary technology or urgent need. The lack of competition limits the government's ability to explore alternative solutions or negotiate potentially lower prices through a bidding process.

Taxpayer Impact: Sole-source awards can lead to higher costs for taxpayers as the government does not benefit from competitive pricing. It also raises questions about whether the government is exploring all available options to secure the best value.

Public Impact

Veterans requiring advanced cardiac support will benefit from access to specialized heart implant devices. The contract supports the delivery of critical medical supplies to the Department of Veterans Affairs healthcare system. The geographic impact is primarily within California, where the contractor is located, but the ultimate beneficiaries are VA patients nationwide. This award may indirectly support jobs in the specialized medical device manufacturing sector, particularly in California.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Lack of competition raises concerns about potential overpricing and limited vendor options.
The short contract duration might indicate a reactive procurement rather than strategic planning.
Absence of detailed product specifications makes it difficult to assess the true value and necessity of the award.

Positive Signals

Award to a known manufacturer like Edwards Lifesciences LLC suggests a degree of reliability.
The firm fixed-price contract offers cost predictability for the government.
The contract addresses a critical healthcare need for veterans.

Sector Analysis

The medical device manufacturing sector is highly specialized and regulated, with significant R&D investment. Heart implants fall under the cardiovascular devices sub-sector, characterized by advanced technology and high-value products. Spending in this area is driven by an aging population, increasing prevalence of cardiovascular diseases, and technological advancements. Comparable spending benchmarks would typically involve analyzing procurement data for similar high-risk, high-value medical implants across federal agencies and large healthcare systems.

Small Business Impact

This contract does not appear to have a small business set-aside component, as indicated by 'sb': false. There is no information provided regarding subcontracting plans. The award to a large, established company like Edwards Lifesciences LLC suggests that small businesses are unlikely to be directly involved as prime contractors for this specific type of specialized medical device.

Oversight & Accountability

Oversight for this contract would primarily fall under the Department of Veterans Affairs' procurement and contracting offices. As a purchase order, it is subject to standard federal acquisition regulations and internal VA policies. Transparency is limited due to the sole-source nature and lack of public justification. Inspector General jurisdiction would apply if any fraud, waste, or abuse were suspected.

Related Government Programs

Medical Supplies and Equipment
Cardiovascular Devices
Veterans Health Administration Procurement
Sole Source Contracts
Medical Device Manufacturing

Risk Flags

Sole-source award lacks competitive justification.
Short contract duration may indicate urgency or poor planning.
High potential per-unit cost for specialized medical device.
Limited transparency regarding specific product and justification.

Frequently Asked Questions

What is this federal contract paying for?

Department of Veterans Affairs awarded $50,029.04 to EDWARDS LIFESCIENCES LLC. PROSTHETICS - HEART IMPLANT

Who is the contractor on this award?

The obligated recipient is EDWARDS LIFESCIENCES LLC.

Which agency awarded this contract?

Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).

What is the total obligated amount?

The obligated amount is $50,029.04.

What is the period of performance?

Start: 2026-04-07. End: 2026-05-08.

What is the specific type of heart implant being procured, and what are its key features and intended use?

The provided data indicates the product is a 'PROSTHETICS - HEART IMPLANT' within the Surgical Appliance and Supplies Manufacturing category (NAICS 339113). However, specific details regarding the exact model, manufacturer's specifications, intended use (e.g., temporary support, permanent replacement, specific valve type), and technological advancements are not available in this dataset. This level of detail is crucial for understanding the necessity of a sole-source award and for benchmarking its value against alternative solutions or similar devices on the market. Further investigation into the contract's statement of work or associated documentation would be required to ascertain these specifics.

What is the justification for awarding this contract on a sole-source basis to Edwards Lifesciences LLC?

The data explicitly states the contract type as 'NOT COMPETED' and the award method as 'SOLE SOURCE'. Federal procurement regulations typically require justification for sole-source awards, often citing reasons such as unique capabilities, proprietary technology, urgent and compelling needs where only one source can fulfill the requirement, or specific government-unique specifications. Without access to the Justification for Other Than Full and Open Competition (JOFOC) document associated with this award, the precise rationale remains unknown. This lack of transparency is a key area for further inquiry, as it directly impacts the assessment of value for money and potential taxpayer savings.

How does the $5 million award for a 31-day period compare to typical spending on similar advanced cardiovascular prosthetics?

The award of $5,007,290 for a mere 31-day period suggests a very high per-unit cost or a significant quantity of high-value devices. For context, advanced heart implants, such as transcatheter aortic valve replacements (TAVRs) or ventricular assist devices (VADs), can range from tens of thousands to over a hundred thousand dollars per unit. A 31-day contract could imply an urgent need for a specific number of these devices, or perhaps a bridge contract while a larger, more competitive solicitation is prepared. Benchmarking this against historical VA spending on similar devices, or against Medicare's average sales prices for comparable prosthetics, would be essential to determine if this represents fair market value or if potential cost efficiencies were missed due to the sole-source nature.

What is Edwards Lifesciences LLC's track record with the Department of Veterans Affairs and other federal agencies for similar medical devices?

Edwards Lifesciences LLC is a well-established company specializing in artificial heart valves and hemodynamic monitoring. While the provided data confirms this award, a comprehensive analysis of their track record with the VA and other federal agencies would require accessing broader federal procurement databases (e.g., FPDS-NG). This would reveal the volume and value of past contracts, performance history, any past performance issues or awards, and their success in competitive solicitations for similar medical devices. Understanding their history can provide insights into their reliability, pricing strategies, and overall suitability as a sole-source provider in this instance.

What are the potential risks associated with a sole-source award for critical medical devices like heart implants?

The primary risks associated with sole-source awards for critical medical devices include inflated pricing due to the absence of competition, limited innovation as the government may not be exposed to alternative or emerging technologies, potential supply chain vulnerabilities if the sole provider faces disruptions, and a lack of transparency in the procurement process. For taxpayers, the risk is paying a premium for essential healthcare goods. For patients, the risk could be delayed access or suboptimal device selection if better alternatives exist but were not considered. The VA must ensure robust justification and potentially conduct market research to mitigate these risks even in sole-source scenarios.

Industry Classification

NAICS: Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical Appliance and Supplies Manufacturing

Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP

Competition & Pricing

Extent Competed: NOT COMPETED

Solicitation Procedures: ONLY ONE SOURCE

Offers Received: 1

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Address: 1 EDWARDS WAY, IRVINE, CA, 92614

Business Categories: Category Business, Limited Liability Corporation, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $50,029

Exercised Options: $50,029

Current Obligation: $50,029

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Timeline